
  
    
      
        
        Viruses_NNP are_VBP intracellular_NN pathogens_NNS that_WDT are_VBP subject_JJ to_TO intense_JJ selective_JJ pressures_NNS
        during_IN their_PRP$ ongoing_JJ battles_NNS within_IN the_DT host_NN ._. To_TO propagate_NN successfully_RB ,_, they_PRP must_MD exploit_VB
        numerous_JJ machineries_NNS of_IN the_DT infected_JJ cell_NN ._. Thus_RB ,_, studies_NNS of_IN their_PRP$ replicative_JJ cycles_NNS have_VBP
        yielded_VBN fundamental_JJ insights_NNS into_IN eukaryotic_JJ biology_NN ._. A_DT prime_JJ example_NN is_VBZ the_DT human_JJ
        immunodeficiency_NN virus_NN (_( HIV_NNP )_) ,_, which_WDT is_VBZ a_DT lentivirus_JJ that_IN causes_VBZ the_DT acquired_VBN
        immunodeficiency_NN syndrome_NN (_( AIDS_NNP )_) ._. Unlike_IN simpler_JJR oncoviruses_NNS that_WDT rely_VBP exclusively_RB on_IN host_NN
        cell_NN machinery_NN ,_, lentiviruses_NNS code_NN for_IN additional_JJ accessory_JJ and_CC regulatory_JJ proteins_NNS that_WDT act_NN
        as_IN molecular_JJ switches_NNS at_IN different_JJ stages_NNS of_IN viral_JJ entry_NN and_CC exit_NN from_IN the_DT infected_JJ cell_NN ._.
        Studying_NNP the_DT actions_NNS of_IN these_DT viral_JJ proteins_NNS has_VBZ yielded_VBN understanding_NN of_IN diverse_JJ cellular_JJ
        functions_NNS such_JJ as_IN the_DT innate_JJ immunity_NN against_IN retroviruses_NNS ,_, control_NN of_IN transcriptional_NN
        elongation_NN ,_, export_NN of_IN macromolecules_NNS from_IN the_DT nucleus_NN to_TO the_DT cytoplasm_NN ,_, and_CC intracellular_NN
        trafficking_NN of_IN proteins_NNS (_( reviewed_VBN in_IN [_NN 1_CD ]_NN )_) ._.
        The_DT transcriptional_NN transactivator_NN (_( Tat_NNP )_) is_VBZ a_DT key_JJ regulatory_JJ protein_NN of_IN HIV_NNP ._. It_PRP is_VBZ
        expressed_VBN early_RB after_IN the_DT virus_NN integrates_NNS into_IN the_DT cell_NN ,_, and_CC stimulates_NNS the_DT elongation_NN of_IN
        RNA_NNP polymerase_NN II_NNP (_( RNAPII_NNP )_) ._. This_DT type_NN of_IN transcriptional_NN control_NN had_VBD not_RB been_VBN previously_RB
        appreciated_VBN ;_: thus_RB ,_, work_NN on_IN Tat_NNP established_VBD a_DT new_JJ paradigm_NN in_IN the_DT field_NN of_IN eukaryotic_JJ
        biology_NN ._. Moreover_RB ,_, these_DT findings_NNS impacted_VBN greatly_RB studies_VBZ of_IN cotranscriptional_NN processing_NN
        of_IN nascent_NN mRNA_NN ._. To_TO understand_VB these_DT processes_VBZ better_JJR ,_, we_PRP need_VBP to_TO start_VB with_IN the_DT basics_NNS of_IN
        transcriptional_NN control_NN ._.
        RNAPII_NNP is_VBZ the_DT enzyme_NN that_WDT transcribes_NNS protein-coding_JJ genes_NNS in_IN eukaryotic_JJ cells_NNS ._. Elegant_NNP
        studies_NNS in_IN vitro_NN first_RB suggested_VBD that_IN the_DT simple_JJ recruitment_NN of_IN RNAPII_NNP to_TO transcription_NN
        units_NNS was_VBD not_RB sufficient_JJ for_IN the_DT copying_NN of_IN genes_NNS and_CC cotranscriptional_NN processing_NN of_IN their_PRP$
        transcripts_NNS ._. Rather_RB ,_, distinct_JJ steps_NNS could_MD be_VB defined_VBN ,_, which_WDT began_VBD with_IN the_DT assembly_NN of_IN the_DT
        preinitiation_NN complex_JJ (_( PIC_NNP )_) ,_, promoter_NN clearance_NN ,_, pausing_VBG ,_, and_CC arrest_NN ,_, and_CC ended_VBD with_IN
        efficient_JJ elongation_NN of_IN transcription_NN (_( reviewed_VBN in_IN [_NN 2_CD ]_NN )_) ._. The_DT central_JJ component_NN of_IN PIC_NNP is_VBZ
        the_DT general_JJ transcription_NN factor_NN (_( GTF_NNP )_) TFIID_NNP ,_, which_WDT contains_VBZ the_DT TATAbox-_NNP binding_JJ protein_NN
        (_( TBP_NNP )_) and_CC 12_CD to_TO 15_CD TBP-associated_NNP factors_NNS (_( TAFs_NNP )_) ._. TFIID_NNP acts_NNS as_IN a_DT “ landing_NN pad_NN” for_IN other_JJ
        GTFs_NNP and_CC RNAPII_NNP to_TO nucleate_NN PIC_NNP assembly_NN ._. Moreover_RB ,_, TAFs_NNP serve_VB as_IN coactivators_NNS to_TO a_DT diverse_JJ
        set_NN of_IN activators_NNS ._. Both_DT an_DT ordered_VBN stepwise_NN assembly_NN and_CC the_DT recruitment_NN of_IN the_DT
        100_CD -_: plus-subunit_JJ “ holoenzyme_NN” have_VBP been_VBN proposed_VBN to_TO be_VB critical_JJ for_IN the_DT positioning_NN of_IN
        RNAPII_NNP at_IN start_NN sites_NNS of_IN transcription_NN ._.
        Next_JJ ,_, the_DT GTF_NNP TFIIH_NNP unwinds_NNS the_DT DNA_NNP ,_, opens_VBZ the_DT transcription_NN bubble_NN ,_, and_CC phosphorylates_NNS
        serines_NNS at_IN position_NN 5_CD in_IN the_DT C-_NNP terminal_NN domain_NN (_( CTD_NNP )_) of_IN the_DT RPB_NNP 1_CD subunit_NN of_IN RNAPII_NNP
        (_( reviewed_VBN in_IN [_NN 2_CD ]_NN )_) ._. This_DT phosphorylation_NN is_VBZ critical_JJ for_IN the_DT recruitment_NN of_IN complexes_NNS that_WDT
        put_VBP a_DT 7_CD -_: methylguanylate_NN cap_NN on_IN the_DT 5_CD ′_NN end_NN of_IN nascent_NN transcripts_NNS ._. After_IN the_DT transcription_NN
        complex_JJ clears_VBZ the_DT promoter_NN ,_, the_DT negative_JJ transcription_NN elongation_NN factor_NN (_( N-TEF_NNP )_) is_VBZ
        recruited_VBN to_TO the_DT RNAPIIa_NNP (_( reviewed_VBN in_IN [_NN 3_CD ]_NN )_) ._. It_PRP consists_VBZ minimally_RB of_IN 5_CD ,_, 6_CD -_:
        dichloro-_NN 1_CD -_: β-_NN D-_NNP ribofuranosylbenzimidazole_NN riboside_NN (_( DRB_NNP )_) -_: sensitivity-inducing_JJ factor_NN
        (_( DSIF_NNP )_) [_NN 4_CD ]_NN and_CC negative_JJ elongation_NN factor_NN (_( NELF_NNP )_) [_NN 5_CD ]_NN ._. They_PRP bind_NN and_CC arrest_NN RNAPII_NNP distal_NN to_TO
        the_DT promoter_NN cooperatively_RB ._. Such_JJ arrested_VBN transcription_NN complexes_NNS have_VBP now_RB been_VBN found_VBN on_IN
        many_JJ inducible_JJ genes_NNS in_IN 
        Drosophila_NNP melanogaster_NN (_( reviewed_VBN in_IN [_NN 6_CD ]_NN )_) and_CC humans_NNS [_NN 7_CD ]_NN ._.
        The_DT transition_NN to_TO robust_JJ elongation_NN depends_VBZ on_IN the_DT positive_JJ transcription_NN elongation_NN
        factor_NN b_SYM (_( P-TEF_NNP b_SYM )_) (_( reviewed_VBN in_IN [_NN 3_CD ]_NN )_) ._. P-TEF_NNP b_SYM contains_VBZ the_DT cyclin-dependent_JJ kinase_NN 9_CD (_( CDK_NNP 9_CD )_)
        and_CC one_CD of_IN four_CD possible_JJ C-_NNP type_NN cyclins_NNS ._. When_WRB recruited_VBN to_TO stalled_VBN transcription_NN complexes_NNS ,_,
        P-TEF_NNP b_SYM phosphorylates_NNS serines_NNS at_IN position_NN 2_CD in_IN the_DT CTD_NNP [_NN 8_CD ]_NN ,_, the_DT Spt_NNP 5_CD subunit_NN of_IN DSIF_NNP [_NN 9_CD ]_NN ,_,
        and_CC the_DT RD_NNP subunit_NN of_IN NELF_NNP [_NN 10_CD ]_NN ._. These_DT modifications_NNS result_VBP in_IN heavily_RB phosphorylated_JJ
        RNAPII_NNP (_( RNAPIIo_NNP )_) ,_, the_DT recruitment_NN of_IN the_DT Elongator_NNP ,_, which_WDT contains_VBZ splicing_VBG and_CC
        polyadenylation_NN machineries_NNS ,_, and_CC the_DT conversions_NNS of_IN DSIF_NNP and_CC NELF_NNP into_IN elongation_NN factors_NNS ._.
        RNAPIIo_NNP now_RB copies_NNS the_DT gene_NN and_CC directs_VBZ the_DT cotranscriptional_NN processing_NN ,_, i_NNP ._. e_SYM ._. ,_, splicing_VBG
        and_CC polyadenylation_NN ,_, of_IN primary_JJ transcripts_NNS ._. Upon_IN successful_JJ polyA_NN addition_NN ,_, the_DT CTD_NNP
        phosphatase_NN FCP_NNP 1_CD dephosphorylates_NNS RNAPIIo_NNP ._. RNAPIIa_NNP dissociates_NNS from_IN DNA_NNP ,_, and_CC the_DT
        transcription_NN cycle_NN starts_VBZ all_DT over_IN again_RB (_( reviewed_VBN in_IN [_NN 2_CD ]_NN )_) ._.
        Tat_NNP is_VBZ unique_JJ among_IN transcriptional_NN activators_NNS in_IN eukaryotic_JJ cells_NNS in_IN that_IN it_PRP functions_NNS
        via_IN RNA_NNP rather_RB than_IN DNA_NNP promoter_NN elements_NNS (_( Figure_NN 1_LS )_) ._. It_PRP binds_NNS the_DT transactivation_NN response_NN
        element_NN (_( TAR_NNP )_) that_IN forms_VBZ a_DT stable_JJ RNA_NNP stem_VB loop_NN at_IN the_DT 5_CD ′_NN end_NN of_IN all_DT viral_JJ transcripts_NNS ._.
        Thus_RB ,_, Tat_NNP requires_VBZ minimally_RB the_DT transcription_NN of_IN TAR_NNP before_IN it_PRP can_MD stimulate_VB HIV_NNP
        transcription_NN from_IN the_DT long_JJ terminal_NN repeat_NN (_( LTR_NNP )_) ._. Indeed_RB ,_, in_IN the_DT absence_NN of_IN Tat_NNP ,_, RNAPIIa_NNP
        clears_VBZ the_DT HIV_NNP LTR_NNP successfully_RB but_CC soon_RB arrests_NNS ,_, yielding_VBG predominantly_RB short_JJ viral_JJ
        transcripts_NNS [_NN 11_CD ]_NN ._. Tat_NNP binds_NNS the_DT 5_CD ′_NN bulge_NN in_IN TAR_NNP via_IN its_PRP$ arginine-rich_JJ motif_NN from_IN positions_NNS
        49_CD to_TO 57_CD ,_, where_WRB a_DT central_JJ arginine_NN (_( R_NN 52_CD )_) is_VBZ key_JJ for_IN this_DT interaction_NN ._. However_RB ,_, this_DT binding_JJ
        is_VBZ not_RB sufficient_JJ for_IN Tat_NNP 's_POS function_NN in_IN vivo_NN ._. Adjacent_NNP to_TO the_DT arginine-rich_JJ motif_NN lie_NN
        N-_NNP terminal_NN core_NN and_CC cysteine-rich_JJ regions_NNS ,_, which_WDT form_VBP the_DT activation_NN domain_NN of_IN the_DT protein_NN ._.
        This_DT activation_NN domain_NN binds_NNS cyclin_NN T_NN 1_CD (_( CycT_NNP 1_LS )_) from_IN P-TEF_NNP b_SYM ,_, whose_WP$ partner_NN is_VBZ CDK_NNP 9_CD [_NN 12_CD ]_NN ._. As_IN
        a_DT consequence_NN ,_, P-TEF_NNP b_SYM and_CC Tat_NNP bind_NN TAR_NNP cooperatively_RB ._. The_DT final_JJ proof_NN that_IN P-TEF_NNP b_SYM is_VBZ the_DT
        cellular_JJ cofactor_NN for_IN Tat_NNP came_VBD from_IN studies_NNS of_IN HIV_NNP transcription_NN in_IN murine_NN cells_NNS ,_, where_WRB the_DT
        introduction_NN of_IN the_DT human_JJ CycT_NNP 1_CD protein_NN restores_NNS Tat_NNP function_NN [_NN 12_CD ]_NN ._. The_DT same_JJ effect_NN can_MD be_VB
        achieved_VBN by_IN substituting_VBG just_RB the_DT tyrosine_NN with_IN the_DT cysteine_NN at_IN position_NN 261_CD ,_, such_JJ as_IN are_VBP
        found_VBN in_IN murine_NN and_CC human_JJ CycT_NNP 1_CD proteins_NNS ,_, respectively_RB [_NN 13_CD ]_NN ._. A_DT paper_NN in_IN this_DT issue_NN of_IN 
        PLoS_NNP Biology_NNP suggests_VBZ that_IN Tat_NNP and_CC P-TEF_NNP b_SYM can_MD also_RB recruit_VB
        TAF-independent_NNP transcription_NN complexes_NNS to_TO the_DT HIV_NNP LTR_NNP [_NN 14_CD ]_NN (_( Figure_NN 1_LS )_) ._. Possibly_RB ,_, this_DT
        assembly_NN reflects_VBZ interactions_NNS between_IN CycT_NNP 1_CD and_CC the_DT unphosphorylated_JJ CTD_NNP of_IN RNAPIIa_NNP
        [_NN 15_CD ]_NN ._.
        The_DT assembly_NN and_CC disassembly_RB of_IN the_DT complex_NN between_IN PTEFb_NNP ,_, Tat_NNP ,_, and_CC TAR_NNP is_VBZ a_DT regulated_VBN
        process_NN in_IN vivo_NN ._. Whereas_IN the_DT phosphorylation_NN of_IN CDK_NNP 9_CD strengthens_VBZ this_DT complex_JJ [_NN 16_CD ]_NN ,_, the_DT
        acetylation_NN of_IN the_DT lysine_NN at_IN position_NN 50_CD in_IN Tat_NNP weakens_VBZ it_PRP [_NN 17_CD ]_NN ._. Upon_IN this_DT disruption_NN ,_,
        acetylated_JJ Tat_NNP is_VBZ liberated_VBD from_IN P-TEF_NNP b_SYM and_CC recruits_VBZ the_DT p_NN 300_CD /_NN CREB-binding_NNP protein–_NN
        associated_VBN factor_NN (_( P-CAF_NNP )_) to_TO the_DT elongating_VBG RNAPIIo_NNP ,_, most_RBS likely_JJ facilitating_VBG chromatin_NN
        remodeling_NN ._. In_IN this_DT issue_NN of_IN PLoS_NNP Biology_NNP ,_, Pagans_NNP et_CC al_NN ._. now_RB demonstrate_VB that_IN acetylated_JJ
        Tat_NNP is_VBZ deacetylated_JJ by_IN SIRT_NNP 1_CD [_NN 18_CD ]_NN (_( Figure_NN 1_LS )_) ._. In_IN this_DT way_NN ,_, Tat_NNP can_MD reassemble_JJ with_IN P-TEF_NNP b_SYM
        on_IN TAR_NNP ._.
        Clearly_RB ,_, P-TEF_NNP b_SYM plays_VBZ a_DT key_JJ role_NN in_IN the_DT control_NN of_IN transcriptional_NN elongation_NN ._. Although_IN
        Tat_NNP was_VBD the_DT first_JJ activator_NN known_VBN that_WDT could_MD recruit_VB P-TEF_NNP b_SYM to_TO initiating_VBG RNAPII_NNP ,_,
        additional_JJ members_NNS of_IN this_DT group_NN were_VBD soon_RB identified_VBN ._. They_PRP include_VBP the_DT androgen_NN receptor_NN ,_,
        c-_NN Myc_NNP ,_, the_DT class_NN II_NNP transactivator_NN (_( CIITA_NNP )_) ,_, myoblast_NN determination_NN protein_NN (_( MyoD_NNP )_) ,_, and_CC
        nuclear_JJ factor_NN κ-_NN B_NNP (_( NF-κB_NNP )_) ._. The_DT last_JJ one_CD is_VBZ of_IN great_JJ interest_NN as_IN it_PRP explains_VBZ how_WRB the_DT HIV_NNP
        genome_NN can_MD be_VB transcribed_JJ before_IN the_DT synthesis_NN of_IN Tat_NNP [_NN 19_CD ]_NN ._. Cellular_NNP activation_NN triggers_VBZ
        the_DT nuclear_JJ translocation_NN of_IN NF-κB_NNP ,_, where_WRB it_PRP binds_NNS the_DT HIV_NNP enhancer_NN ,_, leading_VBG to_TO the_DT
        stimulation_NN of_IN viral_JJ transcription_NN ._. It_PRP is_VBZ not_RB surprising_JJ that_DT proviral_NN latency_NN ,_, in_IN which_WDT
        low_JJ levels_NNS of_IN transcription_NN or_CC only_RB short_JJ HIV_NNP transcripts_NNS containing_VBG TAR_NNP are_VBP observed_VBN ,_,
        would_MD in_IN large_JJ part_NN reflect_VBP the_DT absence_NN of_IN these_DT activators_NNS ._. Indeed_RB ,_, in_IN many_JJ of_IN these_DT
        latently_RB infected_JJ cells_NNS ,_, the_DT induction_NN of_IN NF-κB_NNP or_CC the_DT addition_NN of_IN Tat_NNP leads_VBZ to_TO the_DT
        reactivation_NN of_IN viral_JJ replication_NN and_CC spreading_VBG of_IN the_DT infection_NN [_NN 20_CD ,_, 21_CD ]_NN ._.
        Recently_RB ,_, important_JJ aspects_NNS of_IN the_DT regulation_NN of_IN P-TEF_NNP b_SYM have_VBP been_VBN revealed_VBN (_( Figure_NN 2_LS )_) ._.
        Of_IN interest_NN ,_, P-TEF_NNP b_SYM exists_VBZ in_IN two_CD complexes_NNS in_IN cells_NNS [_NN 22_CD ,_, 23_CD ]_NN ._. The_DT larger_JJR measures_NNS
        approximately_RB 500_CD kDa_NN and_CC contains_VBZ the_DT hexamethylene_NN bisacetamide_NN (_( HMBA_NNP )_) –_NN induced_VBD protein_NN 1_CD
        (_( HEXIM_NNP 1_LS )_) and_CC 7_CD SK_NNP small_JJ nuclear_JJ RNA_NNP (_( snRNA_NN )_) in_IN addition_NN to_TO P-TEF_NNP b_SYM [_NN 24_CD ,_, 25_CD ]_NN ._. In_IN this_DT large_JJ
        complex_NN ,_, Cdk_NNP 9_CD is_VBZ enzymatically_RB inactive_JJ ._. HEXIM_NNP 1_CD was_VBD identified_VBN as_IN the_DT inducible_JJ gene_NN
        following_VBG the_DT exposure_NN of_IN vascular_NN smooth_JJ muscle_NN cells_NNS to_TO a_DT potent_JJ differentiating_VBG agent_NN ,_,
        HMBA_NNP [_NN 26_CD ]_NN ._. 7_CD SK_NNP snRNA_NN is_VBZ one_CD of_IN the_DT most_RBS abundant_JJ snRNA_NN species_NNS ,_, whose_WP$ function_NN remained_VBD a_DT
        mystery_NN for_IN over_IN a_DT decade_NN ._. Of_IN interest_NN ,_, targeting_VBG of_IN P-TEF_NNP b_SYM by_IN HEXIM_NNP 1_CD and_CC 7_CD SK_NNP snRNA_NN
        contributes_VBZ significantly_RB to_TO the_DT control_NN of_IN cell_NN growth_NN and_CC differentiation_NN ._. For_IN example_NN ,_,
        growth_NN signals_NNS liberate_NN P-TEF_NNP b_SYM from_IN the_DT large_JJ complex_NN in_IN the_DT course_NN of_IN cardiac_JJ hypertrophy_NN
        in_IN mice_NNS ,_, a_DT disease_NN characterized_VBN by_IN the_DT enlargement_NN of_IN myocytes_NNS due_JJ to_TO a_DT global_JJ increase_NN in_IN
        mRNA_NN synthesis_NN [_NN 27_CD ]_NN ._. Also_RB ,_, following_VBG stress_NN ,_, ultraviolet_JJ light_JJ ,_, or_CC the_DT administration_NN of_IN
        actinomycin_NN D_NNP and_CC DRB_NNP to_TO cells_NNS ,_, the_DT large_JJ complex_NN is_VBZ converted_VBN to_TO the_DT small_JJ complex_NN to_TO
        stimulate_VB transcription_NN [_NN 22_CD ,_, 23_CD ]_NN ._.
        How_WRB central_NN is_VBZ P-TEF_NNP b_SYM to_TO eukaryotic_JJ transcription_NN ?_. In_IN 
        Saccharomyces_NNP cerevisiae_NN ,_, there_EX are_VBP two_CD candidates_NNS for_IN PTEFb_NNP ,_,
        CTDK-_NNP 1_CD and_CC Bur_NNP 1_CD /_NN 2_CD ._. CTDK_NNP 1_CD -_: negative_JJ but_CC not_RB Bur_NNP 1_CD /_NN Bur_NNP 2_CD -_: negative_JJ yeasts_NNS still_RB grow_VBP ,_, albeit_IN
        poorly_RB and_CC only_RB on_IN rich_JJ media_NNS (_( reviewed_VBN in_IN [_NN 2_CD ]_NN )_) ._. In_IN 
        Caenorhabditis_NNP elegans_NNS ,_, genetic_JJ inactivation_NN of_IN CDK_NNP 9_CD or_CC CycT_NNP 1_CD
        and_CC CycT_NNP 2_CD resulted_VBD in_IN the_DT inhibition_NN of_IN all_DT RNAPII_NNP transcription_NN [_NN 8_CD ]_NN ._. Moreover_RB ,_, in_IN 
        D_NNP ._. melanogaster_NN ,_, following_VBG heat_NN shock_NN ,_, PTEFb_NNP is_VBZ recruited_VBN
        upstream_RB of_IN activated_VBN promoters_NNS [_NN 28_CD ]_NN ._. Although_IN no_DT murine_NN knockouts_NNS of_IN subunits_NNS of_IN P-TEF_NNP b_SYM
        have_VBP been_VBN reported_VBN ,_, DRB_NNP and_CC flavopiridol_NN ,_, two_CD ATP_NNP analogs_NNS that_WDT inhibit_VBP the_DT kinase_NN activity_NN
        of_IN CDK_NNP 9_CD ,_, can_MD inhibit_VB nearly_RB all_DT transcription_NN by_IN RNAPII_NNP in_IN human_JJ cells_NNS [_NN 29_CD ]_NN ._. Indeed_RB ,_, as_IN
        P-TEF_NNP b_SYM is_VBZ a_DT coactivator_NN of_IN potent_JJ activators_NNS that_WDT mediate_VB effects_NNS of_IN enhancers_NNS and_CC can_MD
        itself_PRP activate_VBP transcription_NN when_WRB placed_VBN on_IN sites_NNS distal_NN to_TO promoter_NN elements_NNS [_NN 15_CD ]_NN ,_, it_PRP
        might_MD mediate_VB many_JJ more_JJR signaling_VBG events_NNS than_IN those_DT of_IN heat_NN shock_NN ,_, ultraviolet_JJ light_JJ ,_,
        stress_NN ,_, and_CC hypertrophy_NN ._. Conversely_RB ,_, the_DT inhibition_NN of_IN P-TEF_NNP b_SYM could_MD explain_VB the_DT mode_NN of_IN
        action_NN of_IN some_DT transcriptional_NN repressors_NNS ._. Indeed_RB ,_, the_DT global_JJ transcriptional_NN repressor_NN
        PIE-_NNP 1_CD ,_, the_DT regulator_NN of_IN embryogenesis_NNS in_IN 
        C_NNP ._. elegans_NNS ,_, binds_NNS the_DT histidine-rich_JJ stretch_NN in_IN CycT_NNP 1_CD ,_, thus_RB
        decoying_VBG P-TEF_NNP b_SYM away_RB from_IN RNAPII_NNP and_CC blocking_VBG the_DT elongation_NN of_IN transcription_NN [_NN 30_CD ]_NN ._.
        These_DT are_VBP exciting_JJ findings_NNS and_CC suggest_VBP a_DT plethora_NN of_IN future_JJ experiments_NNS ,_, including_VBG the_DT
        genetic_JJ inactivation_NN of_IN subunits_NNS of_IN P-TEF_NNP b_SYM and_CC isoforms_NNS of_IN HEXIM_NNP 1_CD in_IN the_DT mouse_NN ._. Of_IN special_JJ
        interest_NN are_VBP questions_NNS as_IN to_TO where_WRB to_TO place_VB this_DT mechanism_NN of_IN transcriptional_NN regulation_NN in_IN
        the_DT hierarchy_NN of_IN competing_VBG or_CC complementary_JJ processes_NNS ._. What_WP roles_NNS do_VBP different_JJ P-TEF_NNP b_SYM
        complexes_NNS play_VBP in_IN the_DT transcription_NN of_IN specific_JJ genes_NNS ?_. How_WRB central_JJ will_MD the_DT regulation_NN of_IN
        P-TEF_NNP b_SYM be_VB to_TO cellular_JJ growth_NN ,_, proliferation_NN ,_, and_CC differentiation_NN ,_, and_CC what_WP roles_NNS will_MD it_PRP
        play_VB in_IN normal_JJ development_NN and_CC disease_NN states_NNS ?_. As_IN to_TO HIV_NNP ,_, how_WRB can_MD we_PRP use_VBP our_PRP$ knowledge_NN of_IN
        P-TEF_NNP b_SYM to_TO slow_VB down_RB viral_JJ replication_NN and_CC /_NN or_CC to_TO eliminate_VB the_DT state_NN of_IN proviral_NN latency_NN in_IN
        the_DT host_NN ?_. Obviously_RB ,_, we_PRP are_VBP only_RB at_IN the_DT beginning_NN of_IN this_DT journey_NN ,_, which_WDT promises_VBZ to_TO change_VB
        radically_RB our_PRP$ view_NN of_IN eukaryotic_JJ transcription_NN ._.
      
    
  
